The ROE as of November 2024 (TTM) for BiondVax Pharmaceuticals Ltd. (BVXV) is 44.05%

According to BiondVax Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current ROE is 44.05%. This represents a change of -318.65% compared to the average of -20.15% of the last 4 quarters.

BiondVax Pharmaceuticals Ltd. (BVXV) Historical ROE (quarterly & annually)

How has BVXV ROE performed in the past?

The mean historical ROE of BiondVax Pharmaceuticals Ltd. over the last ten years is -7.39%. The current 44.05% ROE has changed -696.10% with respect to the historical average. Over the past ten years (40 quarters), BVXV's ROE was at its highest in in the December 2018 quarter at 146.67%. The ROE was at its lowest in in the September 2020 quarter at -3004.62%.

BiondVax Pharmaceuticals Ltd. (BVXV) ROE by Quarter and Year

Discovering the peaks and valleys of BiondVax Pharmaceuticals Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BiondVax Pharmaceuticals Ltd. (BVXV) Average ROE

How has BVXV ROE performed in the past?

The current ROE of BiondVax Pharmaceuticals Ltd. (BVXV) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

BiondVax Pharmaceuticals Ltd. (BVXV) ROE vs. Peers

How is BVXV’s ROE compared to its peers?

BiondVax Pharmaceuticals Ltd.’s ROE is greater than First Wave BioPharma, Inc. (-28.76%), greater than Salarius Pharmaceuticals, Inc. (-148.64%), greater than SAB Biotherapeutics, Inc. (-94.04%), less than Vaccinex, Inc. (1.11%), greater than GeoVax Labs, Inc. (-852.58%), greater than Molecular Partners AG (-33.08%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than AN2 Therapeutics, Inc. (-54.72%), greater than Pharvaris N.V. (-36.89%), greater than PepGen Inc. (-62.74%), greater than Can-Fite BioPharma Ltd. (-179.39%), greater than Oramed Pharmaceuticals Inc. (-2.94%), greater than MediWound Ltd. (-75.57%), greater than BioLineRx Ltd. (-225.62%), greater than Surrozen, Inc. (-178.66%), less than Armata Pharmaceuticals, Inc. (182.35%), greater than Pasithea Therapeutics Corp. (-74.63%), less than Oncternal Therapeutics, Inc. (120.03%), greater than Aditxt, Inc. (-607.01%), greater than Adial Pharmaceuticals, Inc. (-291.06%), greater than TransCode Therapeutics, Inc. (-597.47%), less than Reviva Pharmaceuticals Holdings, Inc. (664.92%), greater than Avenue Therapeutics, Inc. (-749.10%),

Build a custom stock screener for BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiondVax Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiondVax Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.